1. A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis. Issue 10 (23rd September 2015) Authors: Sieper, J.; van der Heijde, D.; Dougados, M.; Maksymowych, W. P.; Scott, B. B.; Boice, J. A.; Berd, Y.; Bergman, G.; Curtis, S.; Tzontcheva, A.; Huyck, S.; Weng, H. H. Journal: Arthritis & rheumatology Issue: Volume 67:Issue 10(2015) Page Start: 2702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0757 Quality of life in Patients with Active Nonradiographic Axial Spondyloarthritis After 16 Weeks of Golimumab Treatment. (9th June 2015) Authors: Maksymowych, W.P.; Curtis, S.; Dougados, M.; Bergman, G.; Huyck, S.; Tzontcheva, A.; Sieper, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0388 Long-Term Efficacy and Tolerability of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results of The Open-Label Extension of A Randomized, Double-Blind Study. (15th July 2016) Authors: van der Heijde, D.; Dougados, M.; Maksymowych, W.P.; Braun, J.; Bergman, G.; Curtis, S.P.; Tzontcheva, A.; Philip, G.; Huyck, S.; Sieper, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0399 Efficacy of Golimumab for Nonradiographic Axial Spondyloarthritis: Subgroup Analysis by Baseline MRI and C-Reactive Protein Status. (15th July 2016) Authors: Sieper, J.; van der Heijde, D.; Maksymowych, W.P.; Braun, J.; Bergman, G.; Curtis, S.P.; Tzontcheva, A.; Philip, G.; Huyck, S.; Dougados, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 813 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0423 Patient-Reported Quality of Life in Patients with Baseline Objective Signs of Inflammation and Active Nonradiographic Axial Spondyloarthritis Treated with Golimumab: Results of The Open-Label Extension of A Randomized, Double-Blind Study. (15th July 2016) Authors: Maksymowych, W.P.; Dougados, M.; Sieper, J.; Braun, J.; Bergman, G.; Curtis, S.P.; Tzontcheva, A.; Philip, G.; Huyck, S.; van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0218 Baseline Demographic and Disease Characteristics Associated with Response to Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis. (9th June 2015) Authors: Dougados, M.; Bergman, G.; Maksymowych, W.P.; Curtis, S.; Huyck, S.; Tzontcheva, A.; Sieper, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0238 A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis. (9th June 2015) Authors: Sieper, J.; van der Heijde, D.; Dougados, M.; Maksymowych, W.P.; Boice, J.A.; Bergman, G.; Curtis, S.; Tzontcheva, A.; Huyck, S.; Weng, H.H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗